mRNA vaccines

Search documents
RFK Jr. challenges Secy. Hegseth to a pull up and push up challenge
MSNBC· 2025-08-19 13:20
Two, three. One, two, three. One, two, three.Hi, I'm Robert F. Jenny Jr. ., your AJ Secretary.I'm here with Secretary Hugs from the Department of Defense. And we had our big big body challenge today. 50 pull-ups, 100 push-ups.You try to get under five minutes. How did you We got close. I was about 525.You were right behind me. Jonathan Lamir asking the appropriate question. Why does uh RFK Jr.. who at 70 let's admit it's jacked. We don't know if it's a Donnie Deutsch H you know like HGH thing you know remem ...
Doctor DEBUNKS RFK Jr.'s claims about mRNA vaccines
MSNBC· 2025-08-17 21:18
I'm sure you've heard that Health Secretary Robert F. Kennedy Jr. . made big news recently by announcing that he's cutting 22 mRNA vaccine development programs and additional federal funding for other mRNA technologies.If mRNA sounds familiar, it's because it is. This was the biotechnology platform that allowed for the innovation that was the COVID vaccine, the life-saving COVID vaccine that saved millions of lives in the thick of the pandemic. To justify these cuts, RFK Jr.. said this. As the pandemic show ...
The Rachel Maddow Show - Aug. 11 | Audio Only
MSNBC· 2025-08-12 05:35
happy to have you here. Um, so it was the summer of 2016. It was June 2016 and it was a terrible crime.Um, it happened in a small legal office, a legal office that specialized in uh, real estate and in immigration matters. Um, at this little legal office, somebody saw smoke coming out of the stairwell at that office. They called the fire department.Um, firefighters showed up and they did what brave firefighters do. They charged right into that burning building. Firefighters immediately found the source of t ...
'DANGEROUS DECISION': Trump shamed by health experts for reckless cut of vaccine research money
MSNBC· 2025-08-12 05:29
Over two million lives have been saved because of mRNA technology. It helped us develop CO 19 vaccines in record time. People are going to die because we're cutting short funding for this technology. People are going to die because we are cutting short funding for this technology.That person is Dr. . Jerome Adams. If he looks familiar to you at all, that's because he was surgeon general in Donald Trump's first presidential term, saying now that people are going to die because of a newlyannounced decision by ...
‘Sad day for science’: Doctor calls vaccine funding cut a ‘tragic mistake’
MSNBC· 2025-08-06 15:24
A major change in US health policy this morning. Health and Human Services Secretary Robert F. Kennedy Jr.. announcing he will shift nearly $500 million of federal funding away from the development of MN mRNA technology based vaccines. Now Kennedy is a longtime vaccine skeptic. He's already gutted a vaccine advisory committee.He's cut billions to state health agencies and canceled an ad campaign for the flu shot. Here's what he says about this latest decision. After reviewing the science and consulting top ...
RFK Jr. cuts $500 million in mRNA vaccine contracts
MSNBC· 2025-08-06 14:42
Health Secretary Robert F. Kennedy Jr. . announced yesterday the cutting of nearly $500 million of grants and contracts for developing mRNA vaccines.mRNA shots were first used during the CO 19 pandemic. They instruct the body to produce a fragment of a virus which then sets off an immune response. Unlike traditional vaccines, they can be made within months and quickly altered as the virus changes.Many scientists and infectious disease experts quickly denounce this move and stress the importance of mRNA rese ...
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid
The Motley Fool· 2025-05-16 09:30
Group 1: Investment Opportunities - Equity markets present bargains with stocks that have underperformed but may rebound as conditions improve [1] - Moderna is highlighted as a beaten-down stock with promising prospects due to its advancements in mRNA technology and a strong pipeline of potential products [2][4] - Moderna's revenue guidance is projected at $2 billion, primarily from its COVID vaccine efforts, and the company plans to cut operating expenses by $1.4 billion to $1.7 billion by 2027 [8][9] Group 2: Company-Specific Analysis - Moderna - Moderna's mRNA-4157, a personalized cancer vaccine, has shown strong results in phase 2 studies and is currently in phase 3 trials [6] - The company is also developing a standalone influenza vaccine and a combined COVID/flu shot, both nearing approval [7] - Despite a decline in stock performance over the past three years, Moderna's potential for growth remains strong due to its innovative pipeline and cost-cutting measures [9] Group 3: Investment Risks - Teladoc Health, a telemedicine company, has seen a slowdown in revenue growth and remains unprofitable despite high gross margins [10] - In the first quarter, Teladoc's revenue decreased by 3% year over year to $629.4 million, with a net loss per share of $0.53 [11] - The company faces significant challenges, including a competitive landscape and declining membership in its therapy service, BetterHelp [13][14]